PRECISION ONCOLOGY CONNECT is an international group of experts in the field of detection and treatment of targetable genetic/genomic alterations in various cancers, and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients
Previously known as NTRK CONNECT, this site was updated to PRECISION ONCOLOGY CONNECT in January 2023
PRECISION ONCOLOGY CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Amoy Diagnostics, Bayer, Pierre Fabre Laboratories, Thermo Fisher Scientific and Daiichi Sankyo.
What’s new from PRECISION ONCOLOGY CONNECT
Conference update
Oncogene-addicted NSCLC highlights from ELCC 2026
Expert insights on the latest NSCLC data
Experts
Prof. Nicolas GirardEndorsed by
-
Downloadable
Resources -
4 MIN
-
Mar 2026 -
Video podcast
Pre-analytical phase challenges and biomarker testing in HER2+ metastatic breast cancer
Experts
Dr Carlos Barrios, Prof. Gary Tse, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
23 MIN
-
Mar 2026
-
Patient Support
Personalised treatment in childhood cancer: A journey through NTRK fusion testing
Experts
Linet MenacheryEndorsed by
-
4 MIN
-
Mar 2026
-
Speed ReadInfographic / Flashcard
Select datopotamab deruxtecan-associated adverse events
Prophylaxis, monitoring, and management
Experts
Dr Aaron LisbergEndorsed by
-
Downloadable
Resources -
3 MIN
-
Mar 2026
-
Animated Video
Understanding HER2 testing in gynecological cancers
Best practices and treatment implications
Experts
Prof. Fernando A. SoaresEndorsed by
-
Downloadable
Resources -
8 MIN
-
Feb 2026
-
Video podcast
Metastatic breast cancer: Understanding HER2-low and HER2-ultralow classification
A novel therapeutic framework
Experts
Dr Komal Jhaveri, Oncology Brothers (Moderators)-
Downloadable
Resources -
25 MIN
-
Dec 2025
-
